T Yamauchi, K Miyawaki, Y Semba, M Takahashi… - Leukemia, 2022 - nature.com
Acute myeloid leukemia (AML) is a devastating disease, and clinical outcomes are still far
from satisfactory. Here, to identify novel targets for AML therapy, we performed a genome …